% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Tintelnot:271258,
author = {J. Tintelnot and Y. Xu and T. R. Lesker and M. Schönlein
and L. Konczalla and A. D. Giannou and P. Pelczar and D.
Kylies and V. G. Puelles and A. A. Bielecka and M. Peschka
and F. Cortesi and K. Riecken and M. Jung and L. Amend and
T. S. Bröring and M. Trajkovic-Arsic$^*$ and J. Siveke$^*$
and T. Renné and D. Zhang and S. Boeck and T. Strowig and
F. G. Uzunoglu and C. Güngör and A. Stein and J. R.
Izbicki and C. Bokemeyer and M. Sinn and A. C. Kimmelman and
S. Huber and N. Gagliani},
title = {{M}icrobiota-derived 3-{IAA} influences chemotherapy
efficacy in pancreatic cancer.},
journal = {Nature},
volume = {615},
number = {7950},
issn = {0028-0836},
address = {London [u.a.]},
publisher = {Nature Publ. Group},
reportid = {DKFZ-2023-00390},
pages = {168-174},
year = {2023},
note = {2023 Mar;615(7950):168-174},
abstract = {Pancreatic ductal adenocarcinoma (PDAC) is expected to be
the second most deadly cancer by 2040, owing to the high
incidence of metastatic disease and limited responses to
treatment1,2. Less than half of all patients respond to the
primary treatment for PDAC, chemotherapy3,4, and genetic
alterations alone cannot explain this5. Diet is an
environmental factor that can influence the response to
therapies, but its role in PDAC is unclear. Here, using
shotgun metagenomic sequencing and metabolomic screening, we
show that the microbiota-derived tryptophan metabolite
indole-3-acetic acid (3-IAA) is enriched in patients who
respond to treatment. Faecal microbiota transplantation,
short-term dietary manipulation of tryptophan and oral 3-IAA
administration increase the efficacy of chemotherapy in
humanized gnotobiotic mouse models of PDAC. Using a
combination of loss- and gain-of-function experiments, we
show that the efficacy of 3-IAA and chemotherapy is licensed
by neutrophil-derived myeloperoxidase. Myeloperoxidase
oxidizes 3-IAA, which in combination with chemotherapy
induces a downregulation of the reactive oxygen species
(ROS)-degrading enzymes glutathione peroxidase 3 and
glutathione peroxidase 7. All of this results in the
accumulation of ROS and the downregulation of autophagy in
cancer cells, which compromises their metabolic fitness and,
ultimately, their proliferation. In humans, we observed a
significant correlation between the levels of 3-IAA and the
efficacy of therapy in two independent PDAC cohorts. In
summary, we identify a microbiota-derived metabolite that
has clinical implications in the treatment of PDAC, and
provide a motivation for considering nutritional
interventions during the treatment of patients with cancer.},
cin = {ED01},
ddc = {500},
cid = {I:(DE-He78)ED01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:36813961},
doi = {10.1038/s41586-023-05728-y},
url = {https://inrepo02.dkfz.de/record/271258},
}